Takashi Nagamachi
Keine laufenden Positionen mehr
Profil
Mr. Takashi Nagamachi is President at Ajinomoto Pharmaceuticals Co., Ltd.
He is on the Board of Directors at Ajinomoto Co., Inc.
He received his undergraduate degree from Keio University.
Ehemalige bekannte Positionen von Takashi Nagamachi
| Unternehmen | Position | Ende |
|---|---|---|
| AJINOMOTO CO., INC. | Direktor/Vorstandsmitglied | - |
EA Pharma Co., Ltd.
 EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business. | Vorstandsvorsitzender | - |
Ausbildung von Takashi Nagamachi
| Keio University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AJINOMOTO CO., INC. | Consumer Non-Durables |
| Private Unternehmen | 1 |
|---|---|
EA Pharma Co., Ltd.
EA Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., EA Pharma Co., Ltd. is a specialty pharmaceutical company based in Tokyo, Japan. The Japanese company specializes in digestive diseases such as inflammatory intestinal diseases and focuses on advanced research and development and marketing activities to solve unmet medical needs. EA Pharma Co. provides drug discovery research, development research related to gastrointestinal diseases, and drug discovery base technology research to meet the further medical needs of patients. The company's production department aims to create products that have effective and safety as a drug and ensure the quality of the product. EA Pharma Co. aims to be the largest digestive pharmacy in Japan, which was born in the integration of the digestive business of the Eisai group and the Ajinomoto group's digestive business. | Health Technology |
